Collegium Pharmaceutical, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $11.5M | $87.4M | $170.0M |
| FY2020 | — | $186.0M | $174.1M |
| FY2021 | — | $202.9M | $186.4M |
| FY2022 | — | $194.8M | $173.7M |
| FY2023 | — | $195.4M | $238.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $11.5M | $87.4M | $170.0M |
| FY2020 | — | $186.0M | $174.1M |
| FY2021 | — | $202.9M | $186.4M |
| FY2022 | — | $194.8M | $173.7M |
| FY2023 | — | $195.4M | $238.9M |